Artículos de revistas sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Cyclic guanosine 3',5'-monophosphate".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Srivastava, Uma S., Manohar Lal Thakur y C. Spach. "Cyclic 3′, 5′-adenosine monophosphate and cyclic 3′, 5′-guanosine monophosphate metabolism in malnutrition". Nutrition Research 6, n.º 5 (mayo de 1986): 589–99. http://dx.doi.org/10.1016/s0271-5317(86)80113-0.
Texto completoBoadu, Emmanuel, Svanhild Vaskinn, Elisabeth Sundkvist, Ragnhild Jaeger y Georg Sager. "Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [3H]3′,5′-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles11Abbreviations: 3′,5′-cGMP, guanosine 3′,5′-cyclic monophosphate; 2′,3′-cGMP, guanosine 2′,3′-cyclic monophosphate; N-mb-cGMP, N2-monobutyryl guanosine 3′,5′-cyclic monophosphate; O-mb-cGMP, 2′-O-monobutyryl guanosine 3′,5′-cyclic monophosphate; Db-cGMP, N2,2′-O-dibutyryl guanosine 3′,5′-cyclic monophosphate; Br-cGMP, 8′-bromo guanosine 3′,5′-cyclic monophosphate; Rp-cGMPS, Rp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; Sp-cGMPS, Sp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; 3′,5′-cAMP, Adenosine 3′,5′-cyclic monophosphate; and MRP, multidrug resistance protein." Biochemical Pharmacology 62, n.º 4 (agosto de 2001): 425–29. http://dx.doi.org/10.1016/s0006-2952(01)00682-7.
Texto completoPradelles, Philippe, Jacques Grassi, Danielle Chabardes y Nicole Guiso. "Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase". Analytical Chemistry 61, n.º 5 (marzo de 1989): 447–53. http://dx.doi.org/10.1021/ac00180a014.
Texto completoBeste, Kerstin Y. y Roland Seifert. "cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: Development of a hypothesis based on studies with soluble guanylyl cyclase α1β1". Biological Chemistry 394, n.º 2 (1 de febrero de 2013): 261–70. http://dx.doi.org/10.1515/hsz-2012-0282.
Texto completoMeskini, N., O. MacOvschi, A. F. Prigent, G. Nemoz, P. Chapuy y M. Lagarde. "Decreased Cyclic Nucleotide Phosphodiesterase Activity in Human Peripheral Blood Mononuclear Cells from Elderly Women". Clinical Science 79, n.º 5 (1 de noviembre de 1990): 467–70. http://dx.doi.org/10.1042/cs0790467.
Texto completoMattana, J. y P. C. Singhal. "Effects of atrial natriuretic peptide and cGMP on uptake of IgG complexes by macrophages". American Journal of Physiology-Cell Physiology 265, n.º 1 (1 de julio de 1993): C92—C98. http://dx.doi.org/10.1152/ajpcell.1993.265.1.c92.
Texto completoGéigel, LF y LL Leon. "Cyclic 3'-5' guanosine monophosphate-dependent activity in Leishmania amazonensis". Memórias do Instituto Oswaldo Cruz 98, n.º 4 (junio de 2003): 499–500. http://dx.doi.org/10.1590/s0074-02762003000400012.
Texto completoSanty, L. C. y G. Guidotti. "Reconstitution and characterization of two forms of cyclic nucleotide-gated channels from skeletal muscle". American Journal of Physiology-Endocrinology and Metabolism 271, n.º 6 (1 de diciembre de 1996): E1051—E1060. http://dx.doi.org/10.1152/ajpendo.1996.271.6.e1051.
Texto completoChen, Da-Chung, Shyng-Shiou F. Yuan, Her-Young Su, Shin-Chieh Lo, Shin-Sia Ren y Gwo-Jang Wu. "Urinary cyclic guanosine 3′,5′-monophosphate and cyclic adenosine 3′,5′-monophosphate changes in spontaneous and induced onset active labor". Acta Obstetricia et Gynecologica Scandinavica 84, n.º 11 (17 de octubre de 2005): 1081–86. http://dx.doi.org/10.1111/j.0001-6349.2005.00831.x.
Texto completoHorton, J. K., R. C. Martin, S. Kalinka, A. Cushing, J. P. Kitcher, M. J. O'Sullivan y P. M. Baxendale. "Enzyme immunoassays for the estimation of adenosine 3',5'cyclic monophosphate and guanosine 3',5'cyclic monophosphate in biological fluids". Journal of Pharmacological and Toxicological Methods 29, n.º 4 (agosto de 1993): 234. http://dx.doi.org/10.1016/1056-8719(93)90032-a.
Texto completoHorton, J. K., R. C. Martin, S. Kalinka, A. Cushing, J. P. Kitcher, M. J. O'Sullivan y P. M. Baxendale. "Enzyme immunoassays for the estimation of adenosine 3′,5′ cyclic monophosphate and guanosine 3′,5′ cyclic monophosphate in biological fluids". Journal of Immunological Methods 155, n.º 1 (octubre de 1992): 31–40. http://dx.doi.org/10.1016/0022-1759(92)90268-x.
Texto completoSeymour, Andrea A., Benoni Abboa-Offei, Magdi M. Asaad y W. Lynn Rogers. "Evaluation of SQ 28 603, an inhibitor of neutral endopeptidase, in conscious monkeys". Canadian Journal of Physiology and Pharmacology 69, n.º 10 (1 de octubre de 1991): 1609–17. http://dx.doi.org/10.1139/y91-238.
Texto completoLauria, Michele R., Cynthia A. Standley, Yoram Sorokin, Jill C. Todt, Sidney F. Bottoms, Frank D. Yelian y David B. Cotton. "Brain Natriuretic Peptide and Cyclic Guanosine-3′,5′ Monophosphate in Preeclampsia". Journal of Maternal-Fetal and Neonatal Medicine 5, n.º 3 (enero de 1996): 128–31. http://dx.doi.org/10.3109/14767059609025412.
Texto completoSon, Jong-Keun y John P. N. Rosazza. "Cyclic Guanosine-3′,5′-Monophosphate and Biopteridine Biosynthesis in Nocardia sp". Journal of Bacteriology 182, n.º 13 (1 de julio de 2000): 3644–48. http://dx.doi.org/10.1128/jb.182.13.3644-3648.2000.
Texto completoSiragy, H. M., R. A. Johns, M. J. Peach y R. M. Carey. "Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate." Hypertension 19, n.º 6_pt_2 (junio de 1992): 775–79. http://dx.doi.org/10.1161/01.hyp.19.6.775.
Texto completoNavarro, José Antonio, Félix Javier Jiménez-Jiménez, José Antonio Molina, Julián Benito-León, Elena Cisneros, Teresa Gasalla, Miguel Ortı́-Pareja, Antonio Tallón-Barranco, Fernando de Bustos y Joaquı́n Arenas. "Cerebrospinal fluid cyclic guanosine 3′5′ monophosphate levels in Parkinson's disease". Journal of the Neurological Sciences 155, n.º 1 (febrero de 1998): 92–94. http://dx.doi.org/10.1016/s0022-510x(97)00267-0.
Texto completoTeran, Enrique, Carlos Escudero, Sandra Vivero, Armando Enriquez y Andres Calle. "Intraplatelet Cyclic Guanosine‐3′,5′‐Monophosphate Levels During Pregnancy and Preeclampsia". Hypertension in Pregnancy 23, n.º 3 (enero de 2004): 303–8. http://dx.doi.org/10.1081/prg-200030860.
Texto completoWu, Chung-Pu, Hannah Woodcock, Stephen B. Hladky y Margery A. Barrand. "cGMP (guanosine 3′,5′-cyclic monophosphate) transport across human erythrocyte membranes". Biochemical Pharmacology 69, n.º 8 (abril de 2005): 1257–62. http://dx.doi.org/10.1016/j.bcp.2005.02.005.
Texto completoStroiński, A. y J. Floryszak-Wieczorek. "Guanosine 3′:5′-cyclic monophosphate changes during germination of Hordeum vulgare". Plant Science 42, n.º 1 (diciembre de 1985): 1–4. http://dx.doi.org/10.1016/0168-9452(85)90020-2.
Texto completoBenson, Jeffrey Alan. "The effects of cyclic 3′5′ adenosine monophosphate and cyclic 3′5′ guanosine monophosphate upon sutural expansion by an orthopedic force". American Journal of Orthodontics 88, n.º 2 (agosto de 1985): 175. http://dx.doi.org/10.1016/0002-9416(85)90248-9.
Texto completoHenrich, W. L., E. A. McAllister, P. B. Smith y W. B. Campbell. "Guanosine 3',5'-cyclic monophosphate as a mediator of inhibition of renin release". American Journal of Physiology-Renal Physiology 255, n.º 3 (1 de septiembre de 1988): F474—F478. http://dx.doi.org/10.1152/ajprenal.1988.255.3.f474.
Texto completoLee, S. L., W. W. Wang y B. L. Fanburg. "Nitroprusside inhibits serotonin-induced mitogenesis and tyrosine phosphorylation of smooth muscle cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 270, n.º 3 (1 de marzo de 1996): L362—L367. http://dx.doi.org/10.1152/ajplung.1996.270.3.l362.
Texto completoTitus, Steven A., Xiao Li, Noel Southall, Jianming Lu, James Inglese, Michael Brasch, Christopher P. Austin y Wei Zheng. "A Cell-Based PDE4 Assay in 1536-Well Plate Format for High-Throughput Screening". Journal of Biomolecular Screening 13, n.º 7 (1 de julio de 2008): 609–18. http://dx.doi.org/10.1177/1087057108319977.
Texto completoPrakash, Y. S., Adeyemi Iyanoye, Binnaz Ay, Gary C. Sieck y Christina M. Pabelick. "Store-operated Ca2+Influx in Airway Smooth Muscle". Anesthesiology 105, n.º 5 (1 de noviembre de 2006): 976–83. http://dx.doi.org/10.1097/00000542-200611000-00019.
Texto completoKamynina, Alisa, Sebastian Guttzeit, Philip Eaton y Friederike Cuello. "Nitroxyl Donor CXL-1020 Lowers Blood Pressure by Targeting C195 in Cyclic Guanosine-3’,5’-Monophosphate-Dependent Protein Kinase I". Hypertension 79, n.º 5 (mayo de 2022): 946–56. http://dx.doi.org/10.1161/hypertensionaha.122.18756.
Texto completoBkaily, G. y N. Sperelakis. "Injection of guanosine 5'-cyclic monophosphate into heart cells blocks calcium slow channels". American Journal of Physiology-Heart and Circulatory Physiology 248, n.º 5 (1 de mayo de 1985): H745—H749. http://dx.doi.org/10.1152/ajpheart.1985.248.5.h745.
Texto completoRange, Simon P., Elaine D. Holland, Graham P. Basten y Alan J. Knox. "Regulation of guanosine 3′:5′-cyclic monophosphate in ovine tracheal epithelial cells". British Journal of Pharmacology 120, n.º 7 (marzo de 1997): 1249–54. http://dx.doi.org/10.1038/sj.bjp.0701040.
Texto completoBurke-Wolin, T., C. J. Abate, M. S. Wolin y G. H. Gurtner. "Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate". American Journal of Physiology-Lung Cellular and Molecular Physiology 261, n.º 6 (1 de diciembre de 1991): L393—L398. http://dx.doi.org/10.1152/ajplung.1991.261.6.l393.
Texto completoHegde, V. R., H. Wittreich, M. G. Patel, A. C. Horan, R. F. Hart, J. J. Troyanovich, M. S. Puar y V. P. Gullo. "Naturally produced isocoumarins: inhibitors of calmodulinsensitive cyclic guanosine 3′,5′-monophosphate phosphodiesterase". Journal of Industrial Microbiology 4, n.º 3 (mayo de 1989): 209–13. http://dx.doi.org/10.1007/bf01574078.
Texto completoCummings, James J. y Huamei Wang. "Nitric oxide decreases lung liquid production via guanosine 3′,5′-cyclic monophosphate". American Journal of Physiology-Lung Cellular and Molecular Physiology 280, n.º 5 (1 de mayo de 2001): L923—L929. http://dx.doi.org/10.1152/ajplung.2001.280.5.l923.
Texto completoSugawa, Makoto, Kazuhiko Tamura, Tohru Koide y Shigetaka Naitoh. "Functional roles of cyclic guanosine 3′,5′-monophosphate analogue in cerebral vasodilation". General Pharmacology: The Vascular System 24, n.º 3 (mayo de 1993): 577–84. http://dx.doi.org/10.1016/0306-3623(93)90214-i.
Texto completoLauria, Michele R., Cynthia A. Standley, Yoram Sorokin, Jill C. Todt, Sidney F. Bottoms, Frank D. Yellan y David B. Cotton. "Brain natriuretic peptide and cyclic guanosine-3?,5? monophosphate in pre-eclampsia". Journal of Maternal-Fetal Medicine 5, n.º 3 (mayo de 1996): 128–31. http://dx.doi.org/10.1002/(sici)1520-6661(199605/06)5:3<128::aid-mfm6>3.0.co;2-o.
Texto completoLee, HC. "A Signaling Pathway Involving Cyclic ADP-Ribose, cGMP, and Nitric Oxide". Physiology 9, n.º 3 (1 de junio de 1994): 134–37. http://dx.doi.org/10.1152/physiologyonline.1994.9.3.134.
Texto completoDe Vente, J., H. W. M. Steinbusch y J. Schipper. "A new approach to immunocytochemistry of 3′,5′-cyclic guanosine monophosphate: Preparation, specificity, and initial application of a new antiserum against formaldehyde-fixed 3′,5′-cyclic guanosine monophosphate". Neuroscience 22, n.º 1 (julio de 1987): 361–73. http://dx.doi.org/10.1016/0306-4522(87)90226-0.
Texto completoJarratt-Barnham, Edwin, Limin Wang, Youzheng Ning y Julia M. Davies. "The Complex Story of Plant Cyclic Nucleotide-Gated Channels". International Journal of Molecular Sciences 22, n.º 2 (16 de enero de 2021): 874. http://dx.doi.org/10.3390/ijms22020874.
Texto completoPinto, Emilia Modolo, Fabio R. Faucz, Luana Z. Paza, Gang Wu, Elizabeth S. Fernandes, Jerome Bertherat, Constantine A. Stratakis et al. "Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors". Cancers 12, n.º 2 (22 de febrero de 2020): 506. http://dx.doi.org/10.3390/cancers12020506.
Texto completoMcGrogan, I., S. Lu, S. Hipworth, L. Sormaz, R. Eng, D. Preocanin y E. E. Daniel. "Mechanisms of cyclic nucleotide-induced relaxation in canine tracheal smooth muscle". American Journal of Physiology-Lung Cellular and Molecular Physiology 268, n.º 3 (1 de marzo de 1995): L407—L413. http://dx.doi.org/10.1152/ajplung.1995.268.3.l407.
Texto completoGarty, H., O. Yeger, A. Yanovsky y C. Asher. "Guanosine nucleotide-dependent activation of the amiloride-blockable Na+ channel". American Journal of Physiology-Renal Physiology 256, n.º 5 (1 de mayo de 1989): F965—F969. http://dx.doi.org/10.1152/ajprenal.1989.256.5.f965.
Texto completoBell, Gordon M., Steven A. Atlas, Mark Pecker, Jean E. Sealey, Gary James y John H. Laragh. "Diurnal and Postural Variations in Plasma Atrial Natriuretic Factor, Plasma Guanosine 3′:5′-Cyclic Monophosphate and Sodium Excretion". Clinical Science 79, n.º 4 (1 de octubre de 1990): 371–76. http://dx.doi.org/10.1042/cs0790371.
Texto completoMaeda, Hiroshi, Hiroshi Iranami, Manabu Yamamoto, Koji Ogawa, Yoshihiro Morikawa, Emiko Senba y Yoshio Hatano. "Halothane but Not Isoflurane Attenuates Interleukin 1β– induced Nitric Oxide Synthase in Vascular Smooth Muscle". Anesthesiology 95, n.º 2 (1 de agosto de 2001): 492–99. http://dx.doi.org/10.1097/00000542-200108000-00035.
Texto completoZaffalon, F. G., C. Guimmelette, C. L. V. Leal y F. J. Richard. "268 CYCLIC GUANOSINE MONOPHOSPHATE INHIBITS PHOSPHODIESTERASE 3 ACTIVITY IN PORCINE OOCYTES". Reproduction, Fertility and Development 25, n.º 1 (2013): 282. http://dx.doi.org/10.1071/rdv25n1ab268.
Texto completoLewis, Helen M., M. R. Wilkins, M. J. Kendall y M. R. Lee. "Carbidopa Does Not Affect the Renal Response to Atrial Natriuretic Factor in Man". Clinical Science 77, n.º 3 (1 de septiembre de 1989): 281–85. http://dx.doi.org/10.1042/cs0770281.
Texto completoERENMEMİŞOĞLU, Aydın, Cem SÜER, Sadun TEMOÇİN y Hüseyin BEYDAĞI. "The Possible Role of 3':5'- Cyclic Guanosine Monophosphate in Acetylcholine-Mediated Concraction of Isolated Rat Duodenum". European Journal of Therapeutics 5, n.º 1 (1 de enero de 1994): 16–20. http://dx.doi.org/10.58600/eurjther.1994-5-1-1369-arch.
Texto completoAntonenko, Yuri N., Alexander M. Firsov, Irina G. Rybalkina, Elena A. Kotova, Tatyana I. Rokitskaya y Sergei D. Rybalkin. "The mitochondria-targeted antioxidant SkQ1 can carry adenosine 3′,5′-cyclic monophosphate, but not guanosine 3′,5′-cyclic monophosphate, through artificial and natural membranes". Biochimica et Biophysica Acta (BBA) - Bioenergetics 1859 (septiembre de 2018): e113. http://dx.doi.org/10.1016/j.bbabio.2018.09.333.
Texto completoHo, A. K., K. Hashimoto y C. L. Chik. "3′,5′-Cyclic Guanosine Monophosphate Activates Mitogen-Activated Protein Kinase in Rat Pinealocytes". Journal of Neurochemistry 73, n.º 2 (18 de enero de 2002): 598–604. http://dx.doi.org/10.1046/j.1471-4159.1999.0730598.x.
Texto completoSato, M., K. Abe, K. Takeuchi, M. Yasujima, K. Omata, M. Hiwatari, Y. Kasai, M. Tanno, M. Kohzuki y K. Kudo. "Atrial natriuretic factor and cyclic guanosine 3',5'-monophosphate in vascular smooth muscle." Hypertension 8, n.º 9 (septiembre de 1986): 762–71. http://dx.doi.org/10.1161/01.hyp.8.9.762.
Texto completoOhigashi, T., J. Brookins y J. W. Fisher. "Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production." Journal of Clinical Investigation 92, n.º 3 (1 de septiembre de 1993): 1587–91. http://dx.doi.org/10.1172/jci116740.
Texto completoYamada, Hisafumi, Setsuro Hirai, Chiyo Suzuki-Hori y Hiroshi Nagano. "Achromosomal cleavage of fertilized starfish eggs treated with cyclic guanosine 3′,5′-monophosphate". Journal of Experimental Zoology 235, n.º 2 (agosto de 1985): 247–53. http://dx.doi.org/10.1002/jez.1402350211.
Texto completoReyes-Harde, Magali, Barry V. L. Potter, Antony Galione y Patric K. Stanton. "Induction of Hippocampal LTD Requires Nitric-Oxide-Stimulated PKG Activity and Ca2+ Release From Cyclic ADP-Ribose-Sensitive Stores". Journal of Neurophysiology 82, n.º 3 (1 de septiembre de 1999): 1569–76. http://dx.doi.org/10.1152/jn.1999.82.3.1569.
Texto completoBryan, R. M., M. L. Steenberg, M. Y. Eichler, T. D. Johnson, M. W. Swafford y M. S. Suresh. "Permissive role of NO in alpha 2-adrenoceptor-mediated dilations in rat cerebral arteries". American Journal of Physiology-Heart and Circulatory Physiology 269, n.º 3 (1 de septiembre de 1995): H1171—H1174. http://dx.doi.org/10.1152/ajpheart.1995.269.3.h1171.
Texto completo